Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |